Amid heightened public concern, the cost of prescription drugs is the focus of renewed attention by the Trump administration, the Biden campaign and lawmakers in Congress and state capitals. Proposed actions range from sweeping health care system changes to targeted initiatives that could affect Medicare, Medicaid and private insurance. See KFF’s research, analysis and public opinion data, as well as Kaiser Health News’ journalism, related to prescription drugs and their costs.

  • Your Selections:

Refine Results

date

Topics

Content Type

Tags

Cost Containment Strategies For Prescription Drugs: Assessing The Evidence In The Literature

This report describes and reviews various options to address prescription drug spending growth, including a description of each cost-containment strategy, its use by private or public payers, and a discussion of known evidence about its effectiveness or cost-saving potential. It was prepared for the Kaiser Family Foundation by Jack Hoadley,…

Report Read More

National Survey on Consumers’ Experiences With Patient Safety and Quality Information — Toplines

National Survey on Consumers’ Experiences With Patient Safety and Quality Information — ToplinesThis document includes the complete toplines from a national survey assessing Americans’ perceptions about the quality of health care, their awareness and reported usage of information in making their health care choices, and their experiences with their health…

Poll Finding Read More

State Financing of the Medicare Drug Benefit:  New Data on the “Clawback”

State Financing of the Medicare Drug Benefit: New Data on the “Clawback”Beginning in 2006, states will be obligated to finance part of the new Medicare prescription drug benefit via a monthly “clawback” payment to the federal government. This issue update analyzes the latest data and provides an overview of the…

Issue Brief Read More

Reactions to the New Medicare Law, Findings Based on Focus Groups with People on Medicare

This report, Reactions to the New Medicare Drug Law, produced jointly by a bipartisan team of pollsters from Public Opinion Strategies and Peter D. Hart Research Associates, presents key findings from ten focus groups of people on Medicare in three cities: Pittsburgh, PA; Kansas City, KS, and Washington, DC. The…

Report Read More

USA Today/Kaiser Family Foundation/Harvard School of Public Health Survey: The Public on Prescription Drugs and Pharmaceutical Companies: Summary and Charts

This document provides key findings from a USA Today/Kaiser/Harvard survey examining Americans’ views on, and experiences with, prescription drugs and the pharmaceutical industry, including drug costs, advertisements, safety issues, government regulation and medical research. Summary and Charts (.pdf)

Poll Finding Read More

Medicare Prescription Drug Plans in 2008 and Key Changes Since 2006: Summary of Findings

This synthesis of key findings from analysis presented in a series of eight Medicare Part D 2008 Data Spotlights describes key features of stand-alone prescription drug plans offered in 2008 and trends since 2006. The synthesis covers a range of topics, including premiums, the coverage gap, benefit design, cost sharing,…

Issue Brief Read More

Prescription Drugs: Results from a National Survey

Prescription drugs have become an integral part of medical practice – they help keep people healthy and save lives. But rising prescription drug costs have placed a growing burden on consumers, employers, and public programs. The issue of drug coverage for seniors under Medicare has moved to center stage in…

Fact Sheet Read More

ADAP Issue Brief: AIDS Drug Assistance Programs – Getting the Best Price?

This issue brief, prepared as part of the National ADAP Monitoring Project, examines how ADAPs purchase and dispense drugs, and the drug discount programs that assist states in containing ADAP costs. For more information on the series see the National ADAP Monitoring Project page. Issue Brief

Issue Brief Read More

Medicare Prescription Drug Coverage: Facts, Options, and Implications

Testimony by Patricia Neuman, Sc.D., vice president and director of the Foundation’s Medicare Policy Project, for the House Committee on Energy and Commerce, Subcommittee on Health, hearing on Creating a Medicare Prescription Drug Benefit: begins with a brief review of existing sources of prescription drug coverage for the Medicare population…

Event Read More

Trends and Indicators in the Changing Health Care Marketplace 2002

This chartbook provides information on key trends in the health care marketplace including health spending, the structure of the health care marketplace, and health plan and provider relationships. It highlights data on health plan enrollment, premiums, and benefits, and the implications of health market trends for consumers and the safety…

Report Read More

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.